M7946447
Tafluprostfreeacid(AFP-172) , 98% , 209860-88-8
| Pack Size | Price | Stock | Quantity |
| 1mg | RMB1759.20 | In Stock |
|
| others | Enquire |
Update time: 2022-07-08
PRODUCT Properties
| Boiling point: | 575.9±50.0 °C(Predicted) |
| Density | 1.271±0.06 g/cm3(Predicted) |
| storage temp. | Store at -20°C |
| solubility | DMF: 30 mg/ml; DSMO: 30 mg/ml; Ethanol: 30 mg/ml; PBS (pH 7.2): 3 mg/ml |
| form | Oil |
| pka | 4.76±0.10(Predicted) |
| color | Colorless to light yellow |
| optical activity | [α]/D 17 to 22°, c =1.0 in methanol |
| InChIKey | KIQXRQVVYTYYAZ-VKVYFNERSA-N |
| SMILES | C(O)(=O)CCC/C=C\C[C@H]1[C@@H](O)C[C@@H](O)[C@@H]1/C=C/C(F)(F)COC1=CC=CC=C1 |
Description and Uses
Tafluprost Acid is a derivative of Tafluprost (T004820), a novel prostanoid used in the treatment of glaucoma and is the first prostanoid to be released in a preservative free-formula.
Safety
| Symbol(GHS) |   GHS07,GHS08 |
| Signal word | Danger |
| Hazard statements | H302-H360 |
| Precautionary statements | P264-P270-P301+P312-P330-P501 |
![5-Heptenoic acid, 7-[(1R,2R,3R,5S)-2-[(1E,3R)-4-(3-chlorophenoxy)-3-hydroxy-1-buten-1-yl]-3,5-dihydroxycyclopentyl]-, (5E)-rel-](https://img.chemicalbook.com/CAS/20180808/GIF/72029-43-7.gif)
